Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 50, 2021 - Issue 2-3
178
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

“Clinical Aspects of Chronic Granulomatous Disease in Upper Egypt”

ORCID Icon, , &

References

  • Agochukwu NQ, Rastinehad AR, Richter LA, Barak S, Zerbe CS, Holland SM, Pinto PA. 2012. Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature. J Pediatr Surg. 47(2):400–03.
  • Al-Zadjali S, Al-Tamemi S, Elnour I, AlKindi S, Lapoumeroulie C, Al-Maamari S, Pathare A, Dennison D, Krishnamoorthy R. 2015. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies. Clin Genet. 87(2):185–89.
  • Bakri FG, Martel C, Khuri-Bulos N, Mahafzah A, El-Khateeb MS, Al-Wahadneh AM, Hayajneh WA, Hamamy HA, Maquet E, Molin M, et al. 2009. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol. 29(2):215–30.
  • Ben-Ari J, Wolach O, Gavrieli R, Wolach B. 2012. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression. Expert Rev Anti Infect Ther. 10(8):881–94.
  • Ben-Farhat K, Ben-Mustapha I, Ben-Ali M, Rouault K, Hamami S, Mekki N, Ben-Chehida A, Largueche B, Fitouri Z, Abdelmoula S, et al. 2016. A founder effect of c.257 + 2T > C mutation in NCF2 gene underlies severe chronic granulomatous disease in eleven patients. J Clin Immunol. 36(6):547–54.
  • Boonyawat B, Suksawat Y, Pacharn P, Suwanpakdee P, Traivaree C. 2018. X-linked chronic granulomatous disease: initial presentation with intracranial hemorrhage from vitamin K deficiency in infant. Case Rep Pediatr. 2018:7041204.
  • Brown KL, Bylund J, MacDonald KL, Song-Zhao GX, Elliott MR, Falsafi R, Hancock RE, Speert DP. 2008. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin Immunol. 129(1):90–102.
  • Bylund J, MacDonald KL, Brown KL, Mydel P, Collins LV, Hancock RE, Speert DP. 2007. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur J Immunol. 37(4):1087–96.
  • Conley ME, Notarangelo LD, Etzioni A. 1999. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 93(3):190–97.
  • Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E Jr., Deswarte C, Hubeau M, Karaca N, de Suremain M, et al. 2016. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. J Allergy Clin Immunol. 138(1):241–248 e243.
  • de Oliveira-junior EB, Zurro NB, Prando C, Cabral-Marques O, Pereira PV, Schimke LF, Klaver S, Buzolin M, Blancas-Galicia L, Santos-Argumedo L, et al. 2015. Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin american patients: first report from the LASID registry. Pediatr Blood Cancer. 62(12):2101–07.
  • De Ravin SS, Reik A, Liu PQ, Li L, Wu X, Su L, Raley C, Theobald N, Choi U, Song AH, et al. 2016. Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease. Nat Biotechnol. 34(4):424–29.
  • El Hawary R, Meshaal S, Deswarte C, Galal N, Abdelkawy M, Alkady R, Elaziz DA, Freiberger T, Ravcukova B, Litzman J, et al. 2016. Role of flow cytometry in the diagnosis of chronic granulomatous disease: the egyptian experience. J Clin Immunol. 36(6):610–18.
  • El Kares R, Barbouche MR, Elloumi-Zghal H, Bejaoui M, Chemli J, Mellouli F, Tebib N, Abdelmoula MS, Boukthir S, Fitouri Z, et al. 2006. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet. 51(10):887–95.
  • Falcone EL, Holland SM. 2012. Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management. Curr Opin Infect Dis. 25(6):658–69.
  • Fernandez-Boyanapalli R, Frasch SC, Riches DW, Vandivier RW, Henson PM, Bratton DL. 2010. PPARgamma activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease. Blood. 116(22):4512–22.
  • Fernando SJA, Faiz NM, Handunnetti SM, De Silva AD, Dasanayake W, Wickramasinghe GD, Karunatilake R, de Silva NR. 2018. Preliminary study on chronic granulomatous disease in Sri Lanka. Allergy Asthma Clin Immunol. 14:37.
  • Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Muller NL. 2008. Chest radiographic and CT manifestations of chronic granulomatous disease in adults. AJR Am J Roentgenol. 191(5):1570–75.
  • Holland SM. 2013. Chronic granulomatous disease. Hematol Oncol Clin North Am. 27(1):89–99, viii.
  • Imam IZ. 1985. Immunization and primary health care in Egypt. Trop Geogr Med. 37(3):S65–S66.
  • Johnston RB, Newman SL. 1977. Chronic granulomatous disease. Pediatr Clin North Am. 24(2):365–76.
  • Kang EM, Choi U, Theobald N, Linton G, Long Priel DA, Kuhns D, Malech HL. 2010. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood. 115(4):783–91.
  • Ko SH, Rhim JW, Shin KS, Hahn YS, Lee SY, Kim JG. 2014. Genetic analysis of CYBB gene in 26 korean families with X-linked chronic granulomatous disease. Immunol Invest. 43(6):585–94.
  • Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, DeLeo FR. 2004. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol. 172(1):636–43.
  • Koker MY, Camcioglu Y, van Leeuwen K, Kilic SS, Barlan I, Yilmaz M, Metin A, de Boer M, Avcilar H, Patiroglu T, et al. 2013. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 132(5):1156–1163 e1155.
  • Landing BH, Shirkey HS. 1957. A syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics. 20(3):431–38.
  • Lee PP, Chan KW, Jiang L, Chen T, Li C, Lee TL, Mak PH, Fok SF, Yang X, Lau YL. 2008. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J. 27(3):224–30.
  • Lekstrom-Himes JA, Kuhns DB, Alvord WG, Gallin JI. 2005. Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease. J Immunol. 174(1):411–17.
  • Leusen JH, de Boer M, Bolscher BG, Hilarius PM, Weening RS, Ochs HD, Roos D, Verhoeven AJ. 1994. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest. 93(5):2120–26.
  • Liese JG, Jendrossek V, Jansson A, Petropoulou T, Kloos S, Gahr M, Belohradsky BH. 1996. Chronic granulomatous disease in adults. Lancet. 347(8996):220–23.
  • Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL, Shawker T, Choyke P, Kleiner DE, Schwartzentruber DJ, et al. 2002. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 235(3):383–91.
  • Lutzkanin K, McKeone DJ, Greiner R, Andreae DA. 2019. A novel mutation in chronic granulomatous disease: treating the family, not just the patient. Front Pediatr. 7:107.
  • Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, Yockey L, Darnell DN, Barnhart L, Daub J, et al. 2015. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 60(8):1176–83.
  • Margolis R, Wiener L, Pao M, Malech HL, Holland SM, Driscoll P. 2017. Transition from pediatric to adult care by young adults with chronic granulomatous disease: the patient’s viewpoint. J Adolesc Health. 61(6):716–21.
  • Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, Rossi P, Gattorno M, Rabusin M, Azzari C, et al. 2008. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol. 126(2):155–64.
  • Monies D, Abouelhoda M, AlSayed M, Alhassnan Z, Alotaibi M, Kayyali H, Al-Owain M, Shah A, Rahbeeni Z, Al-Muhaizea MA, et al. 2017. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes. Hum Genet. 136(8):921–39.
  • Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Jandaghi AB, Farhoudi A, Pourpak Z, Moin M, Gharagozlou M, Mansouri D. 2004. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 134(3):253–59.
  • Rae J, Newburger PE, Dinauer MC, Noack D, Hopkins PJ, Kuruto R, Curnutte JT. 1998. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am J Hum Genet. 62(6):1320–31.
  • Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, Sehgal S, Vaiphei K, Kamae C, Honma K, et al. 2014. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 34(1):58–67.
  • Rider NL, Jameson MB, Creech CB. 2018. Chronic granulomatous disease: epidemiology, pathophysiology, and genetic basis of disease. J Pediatric Infect Dis Soc. 7(suppl_1):S2–S5.
  • Segal BH, Han W, Bushey JJ, Joo M, Bhatti Z, Feminella J, Dennis CG, Vethanayagam RR, Yull FE, Capitano M, et al. 2010. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One. 5(3):e9631.
  • Segal BH, Kuhns DB, Ding L, Gallin JI, Holland SM. 2002. Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation. J Leukoc Biol. 71(3):410–16.
  • Shapiro MF, Greenfield S. 1987. The complete blood count and leukocyte differential count. An approach to their rational application. Ann Intern Med. 106(1):65–74.
  • Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. 2011. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy. 9(1):10.
  • Stiehm ER, Fudenberg HH. 1966. Serum levels of immune globulins in health and disease: a survey. Pediatrics. 37(5):715–27.
  • Thomas DC, Charbonnier LM, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, Beenken AE, Lee JC, Clare S, Speak AO, et al. 2019. EROS/CYBC1 mutations: decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 143(2):782–785 e781.
  • Thomas DC, Clare S, Sowerby JM, Pardo M, Juss JK, Goulding DA, van der Weyden L, Storisteanu D, Prakash A, Espeli M, et al. 2017. Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity. J Exp Med. 214(4):1111–28.
  • Thomsen IP, Smith MA, Holland SM, Creech CB. 2016. A comprehensive approach to the management of children and adults with chronic granulomatous disease. J Allergy Clin Immunol Pract. 4(6):1082–88.
  • van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, Espanol T, Fischer A, Kurenko-Deptuch M, Mouy R, et al. 2009. Chronic granulomatous disease: the European experience. PLoS One. 4(4):e5234.
  • Wakabayashi Y, Jubishi D, Okamoto K, Ikeda M, Tatsuno K, Mizoguchi M, Sato T, Okugawa S, Moriya K. 2019. A rare case of a prostatic abscess, bacteremia and chronic granulomatous disease associated with Klebsiella pneumoniae. J Infect Chemother. 25(5):365–67.
  • Winkelstein JA, Marino MC, Johnston RB Jr., Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, et al. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 79(3):155–69.
  • Wolach B, Gavrieli R, de Boer M, van Leeuwen K, Berger-Achituv S, Stauber T, Ben Ari J, Rottem M, Schlesinger Y, Grisaru-Soen G, et al. 2017. Chronic granulomatous disease: clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients. Am J Hematol. 92(1):28–36.
  • Wu J, Wang WF, Zhang YD, Chen TX. 2017. Clinical features and genetic analysis of 48 patients with chronic granulomatous disease in a single center study from Shanghai, China (2005–2015): new studies and a literature review. J Immunol Res. 2017:8745254.
  • Yu G, Hong DK, Dionis KY, Rae J, Heyworth PG, Curnutte JT, Lewis DB. 2008. Focus on FOCIS: the continuing diagnostic challenge of autosomal recessive chronic granulomatous disease. Clin Immunol. 128(2):117–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.